The ability of mammals to protect themselves from invasion by foreign cells or pathogens is controlled primarily by the lymphoid immune system. This system is composed of B cells, which produce antibodies, and T cells, which direct cell-mediated immune responses, Collectively, mature B and T cells have the ability to initiate immune responses against an enormous number of foreign antigens. Recognition of antigens by B cells is mediated through the variable region of their cell surface immunoglobulin receptor (sIg). T-cell antigen recogni tion is mediated by the variable domain of the T-cell receptor (TCR). The genes that encode the sIg and TCR molecules are assembled during B and T cell development, respectively, from individual members of variable (V), diversity (D), and joining (J) gene segment families in a process known as V(D)J recombination. Although V(D)J recombination creates only a single type of TCR or sIg in each individual B or T cell, the combinatorial diversity of the recombination process generates B and T cells ,with > 10s distinct antigenic speciiicities. Subsequent selection processes during B-and T-cell development serve to remove or inactivate cells with receptors that react against self-antigens, Although many of the c&acting elements that regulate the V(D)J recombination process have been defined, relatively little is known about the V(D)J recombinase itself. Present evidence suggests that the same recombinase mediates the rearrangement of both immunoglobulin and T-cell receptor genes. As currently conceived, the V(D)J recombinase must be able to carry out a series of complex reactions, including: recognition of the recombination signal sequences that flank V, D, and J elements; precise cleavage of the DNA substrate at the border between the signal and coding sequences; pairing and ligation of two signal sequences; modification of the end of the coding sequence, including basepair addition and deletion; and coding sequence endligation (Fig. 1) . Based on the large number of events that occur during recombination, it has long been assumed that recombinase activity might require the concerted function of several gene products. Some of the recombinase components are likely to be lymphoid-speciiic, whereas others may play a more general role in DNA repair. Consistent with this hypothesis, the murine sad mutation, which involves a generalized deficiency in double strand DNA break repair, profoundly inhibits the coding sequence ligation step of V(D)J recombination [l] . As a result the ability of scid mice to develop functional B and T cells is impaired and they develop a severe combined immunodeficiency. 180 In 1990, two murine genes, recombinase activating gene (RAG) 1 and 2, were isolated by virtue of their ability to synergistically activate V(D)J recombination in fibroblasts [2] . The two genes are unrelated in amino acid sequence but are located only 8 kilobases (kb) apart on the same chromosome. Although the 5'untranslated regions of the cDNAs of both genes appear to contain spliced exons, the coding sequences of both RAG-1 and RAG-2 are contained within a single exon. The two genes and their organization have been highly conserved in vertebrate evolution. Coexpression of RAG-l and RAG-2 has been observed only in developing lym phoid cells and lymphoid cell lines that have V(D)J recombinase activity. Based on these results, it appears that RAG-l and RAG-2 together either activate the expression of the V(D)J recombinase or are themselves both essential components of the recombinase. RAG-l has been reported to have limited sequence similarity to the yeast gene Hpr-I, which plays a role in regulation of recombination events in yeast, but RAG-2 has not been found to be related to any known gene product. To date, the properties of the protein products of RAG-l and RAG-2 have not been characterized. Thus, the individual roles of these two genes in the regulation of V(D)J recombination has not been established.
Recombination as a genetic control mechanism has been observed frequently in prokatyotes and single cell eukaryotes. With the exception of immunoglobulin-and TCRassociated recombination events, however, developmental recombination has not been observed in vertebrates, despite numerous suggestions that recombination may have additional roles in vertebrate embryogenesis and neural development. It has been speculated that expression of either RAG-1 or RAG-2 alone might have roles in developmental recombination events that are distinct from V(D)J joining. Consistent with this hypothesis, isolated expression of RAG-l has been reported in the murine central nervous system and isolated expression of RAG-2 has been observed in the chicken bursa of Fabricius [3, 4] . The possibility that RAG-1 might play a part in the regulation of genetic recombination in the brain was increased by recent evidence [5] of the rearrangement of a transgene containing V(D)J recombination signal sequences within the central nervous system as well as within lymphoid cells -a pattern that mimics the expression of RAG-l. To test the role of RAG-l and RAG-2 in murine development, separate groups have now performed targeted disruption of each of the genes in the mouse germline and characterized the developmental effects of homozygous deletion of that gene. Mombaerts et al. [6] disrupted RAG-l in the mouse germline, while Shinkai et al. T-cell development in RAG-deficient mice also appears to be arrested at a very early stage. Within the thymus, cells coexpressing the Thy-l antigen and the a chain of the interleukin-2 receptor can be detected. This is the phenotype of the earliest T cells that colonize the normal thymus. However, the cells have no detectable TCR gene rearrangements and do not express CD4 and CD8, even though normal thymocytes express these coreceptor molecules before expressing T-cell receptors on their surface. This suggests, somewhat surprisingly, that RAG gene function is necessary before cells acquire CD4 and CD8 expression. The data suggest that T cells have Apart from the complete deficiency of B and T cells, neither RAG-l nor RAG-2 deficient mice had any observable developmental defects. Mating either RAG-l or RAG-2 heterozygotes produced homozygotic mutant mice at a frequency of approximately 25%. Thus, disruption of neither gene resulted in a significant rate of embryonic lethality. Both RAG-1 and RAG-2 deficient mice were fertile. Both sets of mice have been examined in considerable detail for non-lymphoid pathology, but there were no observable macroscopic, histochemical, or behavioural differences between RAG-deficient mice and control litter mates. Together, these results suggest that neither the recombinase activating genes or V(D)J recombinase activity is absolutely required for the development of non-lymphoid cells.
No defects in the development of the central nervous system of RAG-l deficient mice were seen. The animals have been observed for up to 21 weeks and have apparently failed to develop any neurological abnormalities. The animals can reportedly see, hear, and feel normally, have good motor strength and coordination, and can carry out patterned behavior. The gross and histologic anatomy of the brain suggested that the disruption of RAG-1 function does not interfere with neural development. Thus, pretiously reported [ 51 central nervous system recombination events are either not required for neural development or do not involve RAG-l. The present data, however, do not completely rule out a role for RAG-l in the maintenance of the central nervous system. It has been speculated that RAG-1 may play a role in the suppression of illegitimate recombination in long lived cells such as neurons. Long term observation of the animals and repeated histological examinations will be needed to address this hypothesis. However, the use of scid mice has two potential drawbacks: scid mice have a generalized defect in DNA repair, and the scid immune defect is leaky. As scid animals age, mature B and T cells begin to appear and these cells may mediate transplantation rejection in some animals.
As already noted, mice deficient in RAG-l or RAG-2 have a phenotype very similar to that described for scidmice. In contrast to scidmice, however, no leakiness has been observed in the block to lymphocyte development in RAGdeficient mice. This suggests that RAG-deficient mice may have real advantages for the tissue transplantation studies currently being undertaken in either scid or nude mice.
For example, RAG-deficient mice will be ideal for the production of high titer antibodies from myeloma cells because they are completely deficient in endogenous antibody production. RAG-deficient mice should also be useful for testing and studying the growth of allogeneic and xenogeneic tumours, and they may be even more 
